New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill
Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill
Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging
- Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion
TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging
- Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion
TORONTO-- Conavi Medical Corp.,...